A2 Biotherapeutics has a total of 188 patents globally, out of which 29 have been granted. Of these 188 patents, more than 86% patents are active. The United States of America is where A2 Biotherapeutics has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of A2 Biotherapeutics.
A2 Biotherapeutics was founded in 2018. The company develops a cell therapy that targets cancer by detecting genetic losses specific to tumor cells. Its approach selectively kills cancer cells while sparing healthy ones. This tumor-specific method aims to transform the treatment of solid tumors and improve patient outcomes.
Do read about some of the most popular patents of A2 Biotherapeutics which have been covered by us in this article and also you can find A2 Biotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over A2 Biotherapeutics patent portfolio.
How many patents does A2 Biotherapeutics have?
A2 Biotherapeutics has a total of 188 patents globally. These patents belong to 31 unique patent families. Out of 188 patents, 163 patents are active.
How Many Patents did A2 Biotherapeutics File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | A2 Biotherapeutics Applications Filed | A2 Biotherapeutics Patents Granted |
2025 | 1 | 7 |
2024 | 14 | 15 |
2023 | 30 | 4 |
2022 | 33 | 3 |
2021 | 76 | – |
2020 | 32 | – |
2019 | 1 | – |
How many A2 Biotherapeutics patents are Alive/Dead?
Worldwide Patents

How Many Patents did A2 Biotherapeutics File in Different Countries?

Countries in which A2 Biotherapeutics Filed Patents
Country | Patents |
United States of America | 34 |
Europe (EPO) | 16 |
Japan | 9 |
Australia | 9 |
New Zealand | 8 |
South Africa | 7 |
Israel | 7 |
Brazil | 7 |
China | 7 |
Mexico | 7 |
Korea (South) | 7 |
Canada | 7 |
Singapore | 7 |
Hong Kong (S.A.R.) | 6 |
India | 3 |
Russia | 2 |
Albania | 1 |
Hungary | 1 |
Italy | 1 |
Germany | 1 |
Finland | 1 |
Denmark | 1 |
Malta | 1 |
Serbia | 1 |
Poland | 1 |
Slovenia | 1 |
Croatia | 1 |
Spain | 1 |
Lithuania | 1 |
Portugal | 1 |
Norway | 1 |
Argentina | 1 |
Taiwan | 1 |
Where are Research Centers of A2 Biotherapeutics Patents Located?

10 Best A2 Biotherapeutics Patents
WO2019241549A1 is the most popular patent in the A2 Biotherapeutics portfolio. It has received 66 citations so far from companies like Quell Therapeutics, Ucl Business, Sonoma Biotherapeutics.
Below is the list of 10 most cited patents of A2 Biotherapeutics:
Publication Number | Citation Count |
WO2019241549A1 | 66 |
WO2021030149A1 | 23 |
WO2021096868A1 | 13 |
WO2021222576A1 | 12 |
WO2021119489A1 | 12 |
US11254726B2 | 11 |
WO2021030182A1 | 11 |
WO2022040470A1 | 5 |
WO2022040454A1 | 5 |
WO2022115472A1 | 4 |
What Percentage of A2 Biotherapeutics US Patent Applications were Granted?
A2 Biotherapeutics (Excluding its subsidiaries) has filed 34 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 have been granted leading to a grant rate of 88.89%.
Below are the key stats of A2 Biotherapeutics patent prosecution at the USPTO.

Which Law Firms are managing US Patents for A2 Biotherapeutics?
Law Firm | Total Applications | Success Rate |
Mintz | 24 | 91.67% |
Brown Rudnick Llp | 10 | 100% |
What are A2 Biotherapeutics key innovation segments?
What Technologies are Covered by A2 Biotherapeutics?

The chart below distributes patents filed by A2 Biotherapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where A2 Biotherapeutics thinks it’s important to protect particular technological inventions.

R&D Focus: How has A2 Biotherapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by A2 Biotherapeutics?